Pharmaceutical

STAT+: How a now-retracted study got published in the f...

The experts who scrutinized the manuscript for the journal before it was publish...

Rocket Pharmaceuticals’ RP-A601 receives FDA designations

The fast track designation enables increased communication with the FDA througho...

Astellas Pharma signs licence deal with Kate Therapeuti...

KT430 delivers a functional copy of the MTM1 gene through a new MyoAAV capsid to...

Prescription drug costs for NHS rise by 8% to £10.4bn i...

The Prescription Cost Analysis also highlighted that the drug with the largest i...

FDA committee recommends AstraZeneca and Sanofi’s RSV p...

The committee overwhelmingly supported nirsevimab’s risk-benefit profile in both...

Novaliq’s dry eye disease therapy receives US FDA approval

VEVYE is a topical anti-inflammatory and immunomodulating ophthalmic drug solution.

Upstream Bio raises funds to advance clinical developme...

Upstream Bio’s UPB-101 is currently being assessed in a Phase 1b trial to treat ...

Bristol Myers Squibb gains FDA approval for production ...

The new 244,000ft² facility represents the company’s second significant expansio...

China grants EUA to Covid-19 vaccine against XBB descen...

The vaccine has been developed by WestVac Biopharma along with the West China Me...

The challenges of clinical data management: Can consent...

David McInerney, Cassie Commercial Manager, explains clinical data management ch...

Who’s hiring who? Hiring activity in the Asia-Pacific p...

The Asia-Pacific pharma industry experienced a 2% rise in new job postings in Q1...

STAT+: After gene therapy deaths, Astellas brings in po...

A promising therapy was pulled after four boys died. Now a company wants to sign...

The Canada wildfires are exposing the harmful effects —...

"People that have to work outside all day and they already have underlying condi...

Reanimated hearts donated after death work just as well...

A machine that reanimates hearts could greatly expand the pool of organs for tra...

STAT+: Sen. Cassidy wants to put a stop to FDA delays i...

Sen. Bill Cassidy is concerned about the extended deadlines that can delay the F...

STAT+: Democrats blast Biden administration over Alzhei...

Democrats are ratcheting up their criticism of how the Biden administration is p...